Bluechew Promises a Convenient Way to Get ED Medication, But Does it Work? [Bluechew Review 2020]
Bluechew. It sounds like a kids bubble gum, but it does something more serious for men. It’s Viagra ( sildenafil) or Cialis (tadalafil) in a chewable tablet, and it’s meant to give men their erections back. Around 5 percent of men in their 40’s have complete Erectile Dysfunction problems and 15 percent in their 70s. […]
7 Things You Need to Know About Health Information
Quality healthcare does not depend only on the doctors and nurses who attend to your medical concerns every time you visit a hospital. Aside from these personnel and professionals that you meet during your health checkup, there is an entire workforce making sure that proper healthcare information is provided for the correct treatment and manages […]
Basic Information about HIV and Treatment
HIV treatment involves medication that slows the progression of the virus in the body. HIV is a virus which is called a retrovirus. The drugs used to treat it is called antiretroviral therapy (ART). ART is advised for everyone living with HIV, regardless of how long they have had the virus or how healthy they […]
Sleepless nights, sooner joint replacement surgery? UK study raises the question
A UK Biobank cohort study of adults with hip (n=41,737) or knee pain (n=81,958) found that among patients with knee pain, those who reported “usually” experiencing insomnia symptoms had a higher likelihood of undergoing total knee replacement within the first 4.7 years after enrollment (adjusted hazard ratio, 1.14; 95% confidence interval, 1.04–1.25) compared with those […]
FDA approves Lifyorli plus nab-paclitaxel for platinum-resistant ovarian cancer
Brand name: Lifyorli Generic name: relacorilant Manufacturer: Corcept Therapeutics Inc. Approval date: March 25, 2026 FDA approved Lifyorli (relacorilant), an oral glucocorticoid receptor antagonist, in combination with nab-paclitaxel for the treatment of adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer who’ve received one to three prior systemic regimens, at least one of […]
Promising phase 3 results bring Lyme disease vaccine closer to reality
Pfizer and Valneva announced positive topline results from the phase 3 VALOR trial of their investigational Lyme disease vaccine candidate, PF‑07307405 (LB6V, formerly VLA15), marking a major milestone toward the first approved human vaccine for Lyme disease. In the large, multinational VALOR study involving participants ≥5 years of age, the 6‑valent OspA‑based vaccine demonstrated strong […]
Hormonal contraception not linked to idiopathic intracranial hypertension, meta-analysis finds
A meta-analysis found no evidence that hormonal contraception increases the prevalence of idiopathic intracranial hypertension (IIH). Investigators pooled data from 13 observational studies including 5,351 women with IIH and 669,260 female controls (mean age, ~33 years). Across analyses, hormonal contraceptive use was not associated with IIH prevalence, with pooled effect estimates near unity (odds ratios, […]
Pediatric craniospinal irradiation. Growth deficit and dosimetric aspects.
Abstract Background: Craniospinal irradiation (CSI) has a decisive impact on the control of pediatric tumors with a high probability of dissemination through cerebrospinal fluid, but it is associated with developmental defects of the spine during growth. Objective: To analyze spinal alterations following CRT and to compare the dosimetry of conformal radiotherapy (CRT) and volumetric modulated […]
Lymphoepithelioma-like gastric cancer in Colombia: case reports and literature review.
Abstract Lymphoepithelioma-like gastric cancer (LELGC) is a rare subtype of gastric carcinoma associated with Epstein-Barr virus infection. Although it can manifest as a large tumor mass, it has been reported to have a more favorable prognosis compared to other subtypes. Most of the available evidence comes from Asian countries, with few reports in Latin America. […]
Lymphoepithelioma-like gastric cancer in Colombia: case reports and literature review.
Abstract Lymphoepithelioma-like gastric cancer (LELGC) is a rare subtype of gastric carcinoma associated with Epstein-Barr virus infection. Although it can manifest as a large tumor mass, it has been reported to have a more favorable prognosis compared to other subtypes. Most of the available evidence comes from Asian countries, with few reports in Latin America. […]